NCT03245008 - Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain | Biotech Hunter

Enrollment

626

Participants

Timeline

Start Date

September 8, 2017

Primary Completion Date

December 14, 2019

Study Completion Date

March 9, 2021

Conditions

Osteoarthritis, Knee / Osteoarthritis, Hip

Interventions

DRUG

MT-5547

Solution for injection in pre-filled syringe

DRUG

MT-5547-matching placebo

Solution for injection in pre-filled syringe

Trial Locations (27)

Investigational Site, Aichi

Investigational Site, Aomori

Investigational Site, Chiba

Investigational Site, Ehime

Investigational Site, Fukui

Investigational Site, Fukuoka

Investigational Site, Fukushima

Investigational Site, Gunma

Investigational Site, Hiroshima

Investigational Site, Hokkaido

Investigational Site, Hyōgo

Investigational Site, Ibaraki

Investigational Site, Kagoshima

Investigational Site, Kanagawa

Investigational Site, Kumamoto

Investigational Site, Kyoto

Investigational Site, Mie

Investigational Site, Miyagi

Investigational Site, Miyazaki

Investigational Site, Osaka

Investigational Site, Ōita

Investigational Site, Saitama

Investigational Site, Shiga

Investigational Site, Shizuoka

Investigational Site, Tokyo

Investigational Site, Yamagata

Investigational Site, Yamaguchi